{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:38:26Z","timestamp":1791855506078,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jaad.2010.05.045","type":"journal-article","created":{"date-parts":[[2011,1,15]],"date-time":"2011-01-15T04:17:08Z","timestamp":1295065028000},"page":"217-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":329,"title":["Update on morphea"],"prefix":"10.1016","volume":"64","author":[{"given":"Nicole","family":"Fett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria P.","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2010.05.045_bib1","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in\u00a0Olmsted County 1960-1993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0889-857X(02)00010-8","article-title":"Scleroderma in children and adolescents","volume":"28","author":"Murray","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jaad.2010.05.045_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2010.05.045_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases","volume":"145","author":"Leitenberger","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib6","first-page":"171","article-title":"Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib7","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2010.05.045_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.sder.2007.02.005","article-title":"Deep morphea","volume":"26","author":"Bielsa","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2010.05.045_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2133.2008.08647.x","article-title":"Linear morphoea follows Blaschko\u2019s lines","volume":"159","author":"Weibel","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients","volume":"56","author":"Tollefson","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib12","first-page":"1997","article-title":"Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre","volume":"30","author":"Blaszczyk","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1468-3083.2002.00442.x","article-title":"Scleroderma \u2018en coup de sabre\u2019 and progressive facial hemiatrophy. Is it possible to differentiate them?","volume":"16","author":"Orozco-Covarrubias","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.05.045_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/1534734607308731","article-title":"Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma","volume":"6","author":"Wollina","year":"2007","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.jaad.2010.05.045_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1525-1470.2008.00823.x","article-title":"Lower lip squamous cell carcinoma in disabling pansclerotic morphea of childhood","volume":"26","author":"Petrov","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"2 suppl. 1","key":"10.1016\/j.jaad.2010.05.045_bib16","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.jaad.2004.10.881","article-title":"Disabling pansclerotic morphea: clinical presentation in two adults","volume":"53","author":"Maragh","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib17","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/ard.2008.106302","article-title":"The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy","volume":"68","author":"Matucci-Cerinic","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2010.05.045_bib18","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00296-009-1019-z","article-title":"The role of capillaroscopy in differentiation of primary and secondary Raynaud\u2019s phenomenon in rheumatic diseases: a review of the literature and two case reports","volume":"29","author":"Lambova","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaad.2010.05.045_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archinte.158.6.595","article-title":"Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases","volume":"158","author":"Spencer-Green","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2010.05.045_bib20","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/art.11310","article-title":"Raynaud\u2019s phenomenon and the role of capillaroscopy","volume":"48","author":"Cutolo","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2010.05.045_bib21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/01.bor.0000138677.88694.a4","article-title":"Raynaud phenomenon and the vascular disease in scleroderma","volume":"16","author":"Kahaleh","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib22","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1212\/01.wnl.0000334474.88923.e3","article-title":"Neurologic manifestations of localized scleroderma: a case report and literature review","volume":"71","author":"Kister","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jaad.2010.05.045_bib23","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bjo.2007.116038","article-title":"Ocular involvement in children with localised scleroderma: a multi-centre study","volume":"91","author":"Zannin","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2010.05.045_bib24","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00467-009-1206-x","article-title":"Juvenile linear scleroderma with unique forms of renal involvement","volume":"24","author":"Kasap","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jaad.2010.05.045_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3899\/jrheum.080021","article-title":"Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma","volume":"36","author":"Wozniak","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib26","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archdermatol.2009.202","article-title":"Psychological distress in patients with morphea and eosinophilic fasciitis","volume":"145","author":"Kroft","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/rheumatology\/kep059","article-title":"Health-related quality of life in children and adolescents with juvenile localized scleroderma","volume":"48","author":"Orzechowski","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2010.05.045_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1525-1470.2006.00289.x","article-title":"Deep morphea after vaccination in two young children","volume":"23","author":"Torrelo","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib29","first-page":"1252","article-title":"Vitamin B12-associated localized scleroderma and its treatment","volume":"30","author":"Ho","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2010.05.045_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0536.1994.tb01905.x","article-title":"Sclerodermatous skin reaction after vitamin K1 injections","volume":"31","author":"Guidetti","year":"1994","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2010.05.045_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-4362.1995.tb01569.x","article-title":"Morphea-like reaction from vitamin K1","volume":"34","author":"Morell","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0190-9622(98)70574-2","article-title":"Vitamin K1-induced localized scleroderma (morphea) with linear deposition of IgA in the basement membrane zone","volume":"38","author":"Alonso-Llamazares","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00066-009-2051-3","article-title":"Localized morphea\u2014a rare but significant secondary complication following breast cancer radiotherapy. Case report and review of the literature on radiation reaction among patients with scleroderma\/morphea","volume":"185","author":"Herrmann","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.jaad.2010.05.045_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1440-0960.1999.00330.x","article-title":"Radiation-induced localized scleroderma in breast cancer patients","volume":"40","author":"Bleasel","year":"1999","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib35","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0190-9622(96)90116-4","article-title":"Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation: radiation port scleroderma","volume":"35","author":"Davis","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib36","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/j.1365-2230.2009.03717.x","article-title":"Postirradiation linear morphoea","volume":"35","author":"Akay","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000018322","article-title":"Postirradiation morphea of the breast presentation of two cases and review of the literature","volume":"200","author":"Schaffer","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2010.05.045_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2008.03.009","article-title":"Drug-induced morphea: report of a case induced by balicatib and review of the literature","volume":"59","author":"Peroni","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib39","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archdermatol.2009.131","article-title":"Anti-double-stranded DNA-positive unilateral generalized morphea in an adult, possibly exacerbated by ibuprofen","volume":"145","author":"Kraigher","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00000372-198606000-00005","article-title":"Acrodermatitis chronica atrophicans\u2014a spirochetosis. Clinical and histopathological picture based on 32 patients; course and relationship to erythema chronicum migrans Afzelius","volume":"8","author":"Asbrink","year":"1986","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2010.05.045_bib41","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1365-2133.2007.08235.x","article-title":"Morphoea: a manifestation of infection with Borrelia species?","volume":"157","author":"Eisendle","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib42","first-page":"283","article-title":"Absence of Borrelia burgdorferi antibodies in the sera of Venezuelan patients with localized scleroderma (morphea)","volume":"47","author":"Espinoza-Leon","year":"2006","journal-title":"Invest Clin"},{"key":"10.1016\/j.jaad.2010.05.045_bib43","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1365-2133.2000.03775.x","article-title":"Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction","volume":"143","author":"Weide","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib44","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archderm.1997.03890450126024","article-title":"Borrelia burgdorferi DNA and Borrelia hermsii DNA are not associated with morphea or lichen sclerosus et atrophicus in the southwestern United States","volume":"133","author":"Colome-Grimmer","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2340\/0001555577299304","article-title":"No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A\u00a0prospective study and literature review","volume":"77","author":"Alonso-Llamazares","year":"1997","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2010.05.045_bib46","first-page":"573","article-title":"The absence of antibodies against Borrelia burgdorferi in the sera of Japanese patients with localized scleroderma","volume":"23","author":"Akimoto","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib47","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1600-0560.1996.tb01309.x","article-title":"Role of Borrelia burgdorferi in the pathogenesis of morphea\/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases","volume":"23","author":"De Vito","year":"1996","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2010.05.045_bib48","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/0190-9622(95)91311-4","article-title":"Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea)","volume":"33","author":"Fan","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0190-9622(95)91281-9","article-title":"Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America","volume":"33","author":"Dillon","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/1523-1747.ep12613456","article-title":"No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma","volume":"104","author":"Wienecke","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/3369XXFPEQUNEP5C","article-title":"Focus floating microscopy: \u201cgold standard\u201d for cutaneous borreliosis?","volume":"127","author":"Eisendle","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaad.2010.05.045_bib52","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jaad.2008.09.023","article-title":"\u201cBorrelia-associated early-onset morphea\u201d: a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases","volume":"60","author":"Prinz","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/1529-0131(199801)41:1<10::AID-ART2>3.0.CO;2-P","article-title":"Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis","volume":"41","author":"Pandey","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2010.05.045_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/08916939908994064","article-title":"Autoimmunity and vascular involvement in systemic sclerosis (SSc)","volume":"31","author":"Kahaleh","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaad.2010.05.045_bib55","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1749-6632.2009.04808.x","article-title":"The role of infections in the immunopathogensis of systemic sclerosis\u2014evidence from serological studies","volume":"1173","author":"Arnson","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2010.05.045_bib56","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2010.05.045_bib57","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3899\/jrheum.080098","article-title":"Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A\u00a0single-center study","volume":"35","author":"Arkachaisri","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/keh487","article-title":"Localized scleroderma is an autoimmune disorder","volume":"44","author":"Takehara","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2010.05.045_bib59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/art.11432","article-title":"Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma","volume":"50","author":"Hayakawa","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2010.05.045_bib60","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2010.05.045_bib61","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/ard.60.12.1157","article-title":"Anti-U3 snRNP antibodies in localised scleroderma","volume":"60","author":"Yimane","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2010.05.045_bib62","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","article-title":"Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma","volume":"98","author":"Sgonc","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2010.05.045_bib63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2004.029314","article-title":"Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son","volume":"64","author":"Lambert","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2010.05.045_bib64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/rheumatology\/ken505","article-title":"Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset","volume":"48","author":"Rak","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2010.05.045_bib65","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/rheumatology\/kel297","article-title":"Immunophenotyping of chimeric cells in localized scleroderma","volume":"46","author":"McNallan","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2010.05.045_bib66","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.0303-6987.2004.00203.x","article-title":"Hyperplasia of dermal microvascular pericytes in scleroderma","volume":"31","author":"Helmbold","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2010.05.045_bib67","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0190-9622(00)90010-0","article-title":"Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma","volume":"42","author":"Yamane","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib68","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.1780370218","article-title":"Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud\u2019s phenomenon","volume":"37","author":"Higley","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2010.05.045_bib69","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1600-0625.2008.00828.x","article-title":"Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma","volume":"18","author":"Higashi-Kuwata","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib70","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000094242","article-title":"Chemokines and chemokine receptors in scleroderma","volume":"140","author":"Yamamoto","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaad.2010.05.045_bib71","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/sj.jid.5700331","article-title":"Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma","volume":"126","author":"Asano","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdermsci.2008.04.013","article-title":"Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma","volume":"52","author":"Tomimura","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2010.05.045_bib73","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/art.23595","article-title":"Role of Rac1 in a bleomycin-induced scleroderma model using fibroblast-specific Rac1-knockout mice","volume":"58","author":"Liu","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2010.05.045_bib74","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2133.2008.08592.x","article-title":"Expression of insulin-like growth factor-I in lesional\u00a0and non-lesional skin of patients with morphoea","volume":"159","author":"Fawzi","year":"2008","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.045_bib75","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS One"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210007450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210007450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:19:21Z","timestamp":1759270761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962210007450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0190962210007450"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2010.05.045","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on morphea","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2010.05.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}